Related Experiment Video
Updated: Apr 15, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.4K
When thyroid carcinoma goes bad: a morphological and molecular analysis
1Department of Pathology, Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, 11th Floor, Toronto, ON, M5G 2C4, Canada.
Head and Neck Pathology
|March 26, 2015
Summary
Aggressive thyroid carcinomas require careful pathological assessment of dedifferentiation and invasion. Molecular analysis aids in sub-classification and prognostication of these challenging malignancies.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid carcinomas, originating from follicular epithelium, are common but often indolent.
- A subset exhibits aggressive behavior, including local invasion, recurrence, and metastasis.
- Identifying aggressive subtypes is crucial for effective patient treatment.
Purpose of the Study:
- To review critical aggressive morphologic features in thyroid carcinoma.
- To highlight key molecular mutations associated with thyroid cancer progression.
- To emphasize the importance of histological subtyping and prognostication.
Main Methods:
- Review of literature on thyroid carcinoma morphology and molecular genetics.
- Analysis of pathological features indicative of aggressive disease.
- Integration of molecular findings with clinical outcomes.
Main Results:
- Dedifferentiation is a key indicator of aggressive thyroid carcinoma.
- Histological features like widespread invasion and angioinvasion signify poor prognosis.
- Molecular alterations are increasingly used for sub-classification and prognostication.
Conclusions:
- Accurate histological subtyping and identification of aggressive features are vital for tailoring thyroid cancer treatment.
- Molecular analyses provide deeper insights into thyroid carcinogenesis and prognostication.
- Recognizing aggressive thyroid carcinomas improves patient management and outcomes.
Related Concept Videos
Tumor Progression
8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression
3.6K
3.6K

